In vivo 31P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene

NMR in Biomedicine

Volumn 9, Issue 8, 1996, Pages 364-368

  Stegman, Lauren D ^a   Ben Yoseph, Oded ^a   Freyer, James P ^b   Ross, Brian D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

31P MRS; Brain tumour ganciclovir; Cancer gene therapy; Glioma

Indexed keywords

ANTIVIRUS AGENT; DIAGNOSTIC AGENT; GANCICLOVIR; PHOSPHORUS; THYMIDINE KINASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; GLIOMA; HERPES SIMPLEX VIRUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE RAT; PATHOLOGY; RAT;

ANIMALS; ANTIVIRAL AGENTS; GANCICLOVIR; GLIOMA; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS; RATS; RATS, NUDE; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030299080     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199612)9:8<364::AID-NBM436>3.0.CO;2-W     Document Type: Article

References (41)

1. Kramm, C. M., Sena-Esteves, M., Barnett F. H., Rainov, N. G., Shuback, D. E., Yu, J. S., Pechan, P. A., Paulus, W., Chiocca, E. A. and Breakefield, X. O. Gene therapy for brain tumours. Brain Pathol. 5, 345-381 (1995).
2. Mullen, C. M. Metabolic suicide genes in gene therapy. Pharmacol. Ther. 63, 199-207 (1994).
3. Moolten, F. L. Tumour chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281 (1986).
4. Ezzedine, Z. D., Martuza, R. L., Platika, D., Short, M. P., Malick, A., Choi, B. and Breakefield, X. O. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3, 608-614 (1991).
5. Culver, K. W., Ram, Z., Wallbridge, S., Ishi, H., Oldfield, E. H. and Blaese, R. M. In vivo gene transfer with retroviral-producer cell for treatment of experimental brain tumours. Science 256, 1550-1552 (1992).
6. Takamiya, Y., Short, M. P., Ezzedine, Z. D., Moolten, F. L., Breakefield, X. O. and Martuza, R. L. Gene therapy of malignant brain tumours: a rat glioma line bearing the herpes simplex virus thymidine kinase gene and wild type retrovirus kills other tumour cells. J. Neurosci. Res. 33, 493-503 (1992).
7. Ram, Z., Culver, K. W., Wallbridge, S., Blaese, R. M. and Oldfieid, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumours in rats. Cancer Res. 53, 83-88 (1993).
8. Ram, Z., Culver, K. W., Wallbridge, S., Frank, J. A., Blaese, R. M. and Oldfieid, E. H. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumours. J. Neurosurg. 79, 400-407 (1993).
9. Takamiya, Y., Short, M. P., Moolten, F. L., Fleet, C., Breakefield, X. O. and Martuza, R. L. An experimental model of retrovirus gene therapy for malignant brain tumours. J. Neurosurg. 79, 104-110 (1993).
10. Tapscott, S. J., Miller, A. D., Olsen, J. M., Berger, M. S., Groudine, M. and Spence, A. M. Gene therapy of rat 9L gliosarcoma tumours by transduction with selectable genes does not require drug selection. Proc. Natl Acad. Sci. USA 91, 8185-8189 (1994).
11. Chen, S.-H., Shine, H. D., Goodman, J. C., Grossman, R. G. and Woo, S. L. C. Gene therapy for brain tumours: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl Acad. Sci. USA 91, 3054-3057 (1994).
12. Eliort, G. B. The biochemistry and mechanism of action of acyclovir. J. Antimicr. Chemother. 12, 9-17 (1983).
13. Reid, R., Eng-Chun, M., Eng-Shang, H. and Topal, M. D. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for g-(1,3-dihydroxy-2-propoxymethyl)-guanine triphosphate. J. Biol. Chem. 263, 3898-3904 (1988).
14. Clinical Protocols List. Cancer Gene Ther. 2, 225-234 (1995).
15. Grossman, S. A. and Burch, P. A. Quantitation of tumour response to antineoplastic therapy. Semin. Oncol. 15, 441-454 (1988).
16. Levin, V. A., Crafts, D. C., Norman, D. M., Hoffer, P. B., Spire, J. P. and Wilson, C. B. Criteria for evaluating patients undergoing chemotherapy for malignant brain tumours. J. Neurosurg. 47, 329-335 (1977).
17. Wilson, C. B., Crafts, D. C. and Levin, V. A. Brain tumours: criteria of response and definition of recurrence. Natl Cancer Inst. Monogr. 46, 197-203 (1977).
18. 31P NMR investigation of solid tumours in the living rat. Biosci. Rep. 1, 319-325 (1981).
19. 31P NMR spectroscopy. Radiology 160, 827-830 (1986).
20. Segebarth, C. M., Baleriaux, D. F., Arnold, D. L., Lutyen, P. R. and den Hollander, F. A. P-31 MR spectroscopy in the evaluation of brain tumour treatment. Radiology 165, 215-219 (1987).
21. 31P spectroscopy of large human brain tumours at 1.5 Tesla. Acta Radiol. 29, 77-82 (1988).
22. 31P NMR spectroscopy of subcutaneous 9L gliosarcoma: effects of tumour growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumour bioenergetics and histology. Cancer Res. 48, 676-681 (1988).
23. 31P NMR spectroscopy: a review. Cancer Res. 49, 4075-4085 (1989).
24. 31P nuclear magnetic resonance spectroscopy of rat 9L gliosarcoma treated with BCNU: dose response of spectral changes. Magn. Reson. Med. 11, 258-266 (1989).
25. 31P magnetic resonance spectroscopy. Magn. Reson. Med. 11, 202-208 (1989).
26. Negendank, W. Studies of human tumours by MRS. NMR Biomed. 5, 303-324 (1992).
27. Bullard, D. E., Schold, S. C., Bigner, S. H. and Bigner, D. D. Growth and chemotherapeutic response in athymic mice of tumours arising from human glioma-derived cell lines. J. Neuropathol. Exp. Neurol. 40, 410-427 (1981).
28. 31P nuclear magnetic resonance spectroscopy. Neurology 35, 781-788 (1985).
29. 31P NMR spectroscopy of tumours in vivo. Cancer Biochem. Biophys. 8, 157-166 (1986).
30. Ruiz-Cabello, J. and Cohen, J. S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5, 226-233 (1992).
31. Samejima, Y. and Meruelo, D. 'Bystander killing' induces apoptosis and is inhibited by forskolin. Gene Ther. 2, 50-58 (1995).
32. Colombo, B. M., Benedetti, S., Ottolenghi, S., Mora, M., Pollo, B., Poli, G. and Finocchiaro, G. The 'bystander effect': association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772 (1995).
33. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Keoplin, D. S., Moolten, F. L and Abraham, G. N. The 'bystander effect': tumour regression when a fraction of the tumour mass is genetically modified. Cancer Res. 53, 5274-5283 (1993).
34. Hamel, W., Fick, J. and Israel, M. A. Treatment of HSV-TK expressing cells with ganciclovir induces apoptosis. 11th International Conference on Brain Tumour Research and Therapy. Abstr., p. 108 (1988).
35. Wyllie, A. H. Cell death: a new classification separating apoptosis from necrosis. In Cell Death in Biology and Pathology, ed. by Bowen, I. D. and Lockshin, R. A., pp. 9-34. Chapman and Hall, London (1981).
36. 31P MRS observations of tumour energy metabolism. NMR Biomed. 5, 279-289 (1992).
37. Ram, Z., Wallbridge, S., Shawker, T., Culver, K. W., Blaese, R. M. and Oldfield, E. H. The effect of thymidine kinase transduction and ganciclovir therapy on tumour vasculature and growth of 9L gliomas in rats. J. Neurosurg. 81, 256-260 (1994).
38. Freyer, J. P., Schor, P. L., Jarrett, K. A., Neeman, M. and Sillerud, L. O. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumour spheroids. Cancer Res. 51, 3831-3837 (1991).
39. Freyer, J. P., Linford, H., Lovejoy, V. and Moore, G. H. Correlation between alterations in phophomonoesters and cellular proliferation during recovery from quiescence in a tumour model. 2nd Annual Meeting of the Society for Magnetic Resonance in Medicine. Abstr., p. 451 (1994).
40. Smith, T. A. D., Eccles, S., Ormerod, M. G., Tombs, A. J., Titley, J. C. and Leach, M. O. The phosphocholine and glycerophosphocholine content of and oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J. Cancer 64, 821-826 (1991).
41. 31P NMR analysis of phosphocholine metabolism in rat glioma cells. Magn. Res. Med. 32, 310-318 (1994).